Sagimet Biosciences Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Sagimet Biosciences Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Sagimet Biosciences Inc - Ordinary Shares - Class A
Rating: 1.99333325
Author: Trendlyne DVM scores

about

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

8.25 0.14 (1.73%)

376.88% Gain from 52W Low

556.0K

XNAS Volume

XNAS 03 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.8 / 100

Technically Bullish

70.9 / 100

1Yr Price target upside is 270%

8 analysts

Sagimet Biosciences Inc - ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sagimet Biosciences Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

376.88% Gain from 52W Low

SWOT Analysis

Sagimet Biosciences Inc - ... Live Price Chart